Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2012, Article ID 121702, 6 pages
http://dx.doi.org/10.1155/2012/121702
Research Article

Increased IgG4-Positive Plasma Cells in Granulomatosis with Polyangiitis: A Diagnostic Pitfall of IgG4-Related Disease

1Division of Anatomic Pathology, Mayo Clinic, Rochester, MN 55905, USA
2Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, MN 55905, USA

Received 1 December 2011; Revised 15 February 2012; Accepted 16 February 2012

Academic Editor: Yoh Zen

Copyright © 2012 Sing Yun Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. O. Leslie and M. R. Wick, Practical Pulmonary Pathology: A Diagnostic Approach, Elsevier Saunders, Philadelphia, Pa, USA, 2nd edition, 2011.
  2. E. S. Yi and T. V. Colby, “Wegener's granulomatosis,” Seminars in Diagnostic Pathology, vol. 18, no. 1, pp. 34–46, 2001. View at Google Scholar
  3. W. Cheuk and J. K. Chan, “IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity,” Advances in Anatomic Pathology, vol. 17, no. 5, pp. 303–332, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. T. C. Smyrk, “Pathological features of IgG4-related sclerosing disease,” Current Opinion in Rheumatology, vol. 23, no. 1, pp. 74–79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. P. H. Kalina, J. T. Lie, R. J. Campbell, and J. A. Garrity, “Diagnostic value and limitations of orbital biopsy in Wegener's granulomatosis,” Ophthalmology, vol. 99, no. 1, pp. 120–124, 1992. View at Google Scholar · View at Scopus
  6. K. O. Devaney, W. D. Travis, G. Hoffman, R. Leavitt, R. Lebovics, and A. S. Fauci, “Interpretation of head and neck biopsies in Wegener's granulomatosis. A pathologic study of 126 biopsies in 70 patients,” American Journal of Surgical Pathology, vol. 14, no. 6, pp. 555–564, 1990. View at Google Scholar · View at Scopus
  7. “Design of the wegener's granulomatosis etanercept trial (WGET),” Controlled Clinical Trials, vol. 23, no. 4, pp. 450–468, 2002.
  8. J. H. Stone, “Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial,” Arthritis and Rheumatism, vol. 48, no. 8, pp. 2299–2309, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Vaglio, J. D. Strehl, B. Manger et al., “IgG4 immune response in Churg-Strauss syndrome,” Annals of the Rheumatic Diseases, vol. 71, pp. 390–393, 2012. View at Publisher · View at Google Scholar
  10. T. Kamisawa, N. Funata, Y. Hayashi et al., “A new clinicopathological entity of IgG4-related autoimmune disease,” Journal of Gastroenterology, vol. 38, no. 10, pp. 982–984, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Zhang, K. Notohara, M. J. Levy, S. T. Chari, and T. C. Smyrk, “IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis,” Modern Pathology, vol. 20, no. 1, pp. 23–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. V. Deshpande, S. Chicano, D. Finkelberg et al., “Autoimmune pancreatitis: a systemic immune complex mediated disease,” American Journal of Surgical Pathology, vol. 30, no. 12, pp. 1537–1545, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Dhall, A. A. Suriawinata, L. H. Tang, J. Shia, and D. S. Klimstra, “Use of immunohistochemistry for IgG4 in the distinction of autoimmune pancreatitis from peritumoral pancreatitis,” Human Pathology, vol. 41, no. 5, pp. 643–652, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Shrestha, H. Sekiguchi, T. V. Colby et al., “Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology,” American Journal of Surgical Pathology, vol. 33, no. 10, pp. 1450–1462, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Umehara, K. Okazaki, Y. Masaki et al., “Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011,” Modern Rheumatology, vol. 22, no. 1, pp. 21–30, 2011. View at Publisher · View at Google Scholar
  16. A. Khosroshahi and J. H. Stone, “A clinical overview of IgG4-related systemic disease,” Current Opinion in Rheumatology, vol. 23, no. 1, pp. 57–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Gunton, J. Stiel, P. Clifton-Bligh, E. Wilmshurst, and A. McElduff, “Prevalence of positive anti-neutrophil cytoplasmic antibody (ANCA) in patients receiving anti-thyroid medication,” European Journal of Endocrinology, vol. 142, no. 6, pp. 587–590, 2000. View at Google Scholar · View at Scopus
  18. M. Pillinger and R. Staud, “Wegener's granulomatosis in a patient receiving propylthiouracil for Graves' disease,” Seminars in Arthritis and Rheumatism, vol. 28, no. 2, pp. 124–129, 1998. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Raissian, S. H. Nasr, C. P. Larsen et al., “Diagnosis of IgG4-related tubulointerstitial nephritis,” Journal of the American Society of Nephrology, vol. 22, no. 7, pp. 1343–1352, 2011. View at Publisher · View at Google Scholar
  20. D. C. Houghton and M. L. Troxell, “An abundance of IgG4 plasma cells is not specific for IgG4-related tubulointerstitial nephritis,” Modern Pathology, vol. 24, no. 11, pp. 1480–1487, 2011. View at Publisher · View at Google Scholar
  21. J. D. Strehl, A. Hartmann, and A. Agaimy, “Numerous IgG4-positive plasma cells are ubiquitous in diverse localised non-specific chronic inflammatory conditions and need to be distinguished from IgG4-related systemic disorders,” Journal of Clinical Pathology, vol. 64, no. 3, pp. 237–243, 2011. View at Publisher · View at Google Scholar
  22. E. Brouwer, J. W. Tervaert, G. Horst et al., “Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders,” Clinical and Experimental Immunology, vol. 83, no. 3, pp. 379–386, 1991. View at Google Scholar · View at Scopus
  23. M. Holland, P. Hewins, M. Goodall, D. Adu, R. Jefferis, and C. O. Savage, “Anti-neutrophil cytoplasm antibody IgG subclasses in Wegener's granulomatosis: a possible pathogenic role for the IgG4 subclass,” Clinical and Experimental Immunology, vol. 138, no. 1, pp. 183–192, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Hussain, T. Pankhurst, M. Goodall et al., “Chimeric IgG4 PR3-ANCA induces selective inflammatory responses from neutrophils through engagement of Fcgamma receptors,” Immunology, vol. 128, no. 2, pp. 236–244, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. J. Liu, M. Chen, F. Yu, M. H. Zhao, and H. Y. Wang, “IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis,” Nephrology, vol. 13, no. 7, pp. 629–635, 2008. View at Publisher · View at Google Scholar · View at Scopus